Evidio Domingo-Musibay – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailmusib024umnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

7 Finished
7 Active

14 results

Research project
A Phase 2, Multicenter Study to Assess the Safety and Ef
Domingo-Musibay, E.
IOVANCE BIOTHERAPEUTICS
5/1/17 → 12/31/24
Project: Research project
CITN-09: A Phase II Study of MK-3475 in Patients with Ad
Domingo-Musibay, E.
Fred Hutchinson Cancer Research Center
9/1/16 → 4/11/17
Project: Research project
A US Multi-Site Observational Study in Patients with Unr
Domingo-Musibay, E.
BRISTOL-MYERS SQUIBB COMPANY
5/1/16 → 6/30/21
Project: Research project
An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies
Domingo-Musibay, E.
Seattle Genetics, Inc.
9/15/21 → 9/15/26
Project: Research project
MT2020-36: A Phase 2, Open-label, Multicenter Study Evaluating the Safety and Efficacy of AutologousTumor-infiltrating Lymphocytes (TILs) in Subjects with Advanced Melanoma
Domingo-Musibay, E.
INSTIL BIO, INC
10/28/20 → 10/31/25
Project: Research project
Immunomodulatory affects of radioembolization: a prospective study of peripheral monocyte modulation, immune cell infiltration, and cytokine variation.
Young, S. J., Domingo-Musibay, E., Golzarian, J. & Lou, E.
RADIOLOGICAL SOC OF NORTH AMERICA
7/1/20 → 6/30/22
Project: Research project
Neoadjuvant therapy for patients with high risk stage III melanoma
Domingo-Musibay, E. & Holtan, S. G.
Mayo Clinic
6/1/18 → 11/30/24
Project: Research project
A PHASE 1/2, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY OFNKTR-262 IN COMBINATION WITH NKTR-214 AND IN COMBINATION WITH NKTR-214 PLUS NIVOLUMABIN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES
Domingo-Musibay, E.
NEKTAR THERAPEUTICS
5/1/18 → 5/31/22
Project: Research project
MMP-01: Pilot Study Evaluating Activity of the Combination of Anti-PD-1 Antibody with High Dose IL-2 in Metastatic Melanoma
Domingo-Musibay, E.
HOOSIER CANCER RESEARCH NETWORK, INC.
8/12/19 → 12/31/19
Project: Research project
Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy
Domingo-Musibay, E.
BRISTOL-MYERS SQUIBB COMPANY
2/1/19 → 1/30/20
Project: Research project
A Phase 1/2 non-randomized, open-label, multi-cohort, multi-center study assessing the clinical benefit ofSAR444245 (THOR- 707) combined with cemiplimab for the treatment of participants with advancedunresectable or metastatic skin cancers
Domingo-Musibay, E.
SANOFI-AVENTIS US
8/5/21 → 8/31/26
Project: Research project
A Phase 1b/2 Study of Hypofractionated Radiation (HD-XRT
Domingo-Musibay, E.
Prometheus Laboratories, Inc.
5/1/17 → 8/31/22
Project: Research project
A Phase 1b/2, Open-label, Multicenter, Dose-escalation a
Domingo-Musibay, E.
DYNAVAX TECHNOLOGIES CORPORATION
9/1/16 → 11/30/18
Project: Research project
Single Arm Phase II Study of Ipilimumab and Nivolumab as
Domingo-Musibay, E. & Holtan, S. G.
BIG TEN CANCER RESEARCH CONSORTIUM
12/1/17 → 12/31/23
Project: Research project